Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

LivePersons Financial Performance for Q4 2023 A Mixed Bag

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
Technology Blockchain Markets and money
0
SHARES
19
VIEWS
Share on FacebookShare on Twitter

LivePerson’s financial performance for Q4 2023 was a mixed bag, with total revenue reaching $95.5 million, slightly surpassing their forecast but down 22.1% from the previous year. The company reported a loss of $40.5 million, translating to losses per share of 48 cents, missing Wall Street’s projections. Looking ahead to Q1 2024, LivePerson’s revenue guidance fell short of expectations, with estimates between $79 million to $83 million for the quarter and full-year revenue projected at $300 million to $315 million. Following these results, LivePerson’s shares took a hit in the market.

LivePerson Inc. (LPSN) Stock Plummets 42.92% on February 29, 2024

On February 29, 2024, LivePerson Inc. (LPSN) experienced a significant drop in its stock price, trading near the bottom of its 52-week range and below its 200-day simple moving average. The stock opened at $1.71, which was $0.69 lower than its previous close, and saw a decrease of $1.03 since the market last closed, resulting in a 42.92% drop.

LPSN Stock Performance Analysis: Revenue Up, Net Income Down – February 29, 2024

On February 29, 2024, LPSN stock experienced mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was reported at $514.80 million, which represented a 9.62% increase compared to the previous year. In the third quarter, LPSN generated $101.33 million in total revenue, reflecting a 3.91% increase from the previous quarter.

However, despite the growth in total revenue, LPSN’s net income showed a significant decline. The company reported a net income of -$225.75 million for the past year, marking an 80.64% decrease from the previous year. In the third quarter, LPSN recorded a net income of -$53.31 million, which represented a staggering 592.63% decrease from the previous quarter.

Furthermore, LPSN’s earnings per share (EPS) also experienced a decline. The company reported an EPS of -$3.03 for the past year, reflecting a 68.75% decrease from the previous year. In the third quarter, LPSN’s EPS was reported at -$0.68, indicating a 677.68% decrease from the previous quarter.

Overall, LPSN’s stock performances on February 29, 2024, were impacted by the significant decline in net income and EPS, despite the growth in total revenue. Investors may need to closely monitor the company’s financial performance and strategic initiatives to assess its long-term growth potential and stock value.

Tags: LPSN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finances-and-tech

The Lucrative Investment Opportunity of HR Block NYSE HRB Stock

Finances

Analyzing Perspectives on CCC Intelligent Solutions Insights from Financial Experts

Finance_Financialization

Analyst Ratings and Price Targets for Advance Auto Parts A Breakdown

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com